Philips: strategic collaboration with Israel's IBEX

(CercleFinance.com) - Philips today announced a strategic collaboration with Ibex Medical Analytics, an Israeli specialist in artificial intelligence (AI) based cancer diagnostics.


Both companies intend to jointly promote their digital pathology and AI solutions to hospitals, healthcare networks and laboratories worldwide.

The combination of Philips' IntelliSite Pathology Solution and Ibex's Galen AI cancer diagnostic platform will generate objective and reproducible results, increase confidence in diagnosis and address the ever-increasing demand for pathology-based diagnostics.

In addition to these productivity gains, these solutions will also serve a quadruple purpose by generating more accurate diagnoses, improving the patient and staff experience, while reducing the cost of care, Philips said.


Copyright (c) 2021 CercleFinance.com. All rights reserved.